Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,900 | -39,800 | -28,300 | -20,300 | 57,500 |
| Depreciation Amortization | 36,900 | 25,600 | 16,900 | 8,400 | 33,500 |
| Income taxes - deferred | -17,000 | -1,600 | -1,900 | 300 | -6,800 |
| Accounts receivable | -800 | 7,900 | 26,200 | 15,500 | 67,400 |
| Accounts payable and accrued liabilities | -83,600 | -72,100 | -64,600 | -19,700 | -64,000 |
| Other Working Capital | -59,600 | -65,100 | -48,200 | -15,900 | -143,400 |
| Other Operating Activity | 95,500 | 73,500 | 44,900 | 8,600 | -89,800 |
| Operating Cash Flow | $-74,500 | $-71,600 | $-55,000 | $-23,100 | $-145,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50,600 | -42,500 | -35,400 | -12,500 | -49,100 |
| Net Acquisitions | -57,500 | -57,500 | -7,000 | N/A | 688,600 |
| Investing Cash Flow | $-108,100 | $-100,000 | $-42,400 | $-12,500 | $639,500 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -200 | -200 | -200 | N/A | -339,000 |
| Common Stock Issued | 5,300 | 5,200 | 2,600 | 200 | 17,100 |
| Common Stock Repurchased | -3,600 | -3,400 | -3,300 | -1,900 | -900 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,600 |
| Financing Cash Flow | $1,500 | $1,600 | $-900 | $-1,700 | $-324,400 |
| Exchange Rate Effect | 1,900 | -100 | 1,900 | 1,100 | -4,700 |
| Beginning Cash Position | 384,500 | 384,500 | 384,500 | 384,500 | 219,700 |
| End Cash Position | 205,300 | 214,400 | 288,100 | 348,300 | 384,500 |
| Net Cash Flow | $-179,200 | $-170,100 | $-96,400 | $-36,200 | $164,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,500 | -71,600 | -55,000 | -23,100 | -145,600 |
| Capital Expenditure | -50,600 | -42,500 | -35,400 | -12,500 | -49,100 |
| Free Cash Flow | -125,100 | -114,100 | -90,400 | -35,600 | -194,700 |